AIFA — authorised 9 November 2016
- Marketing authorisation holder: Pfizer Limited
- Status: approved
🇮🇹 Ibrance in Italy
AIFA authorised Ibrance on 9 November 2016
Marketing authorisation
Ibrance in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Italy
Frequently asked questions
Is Ibrance approved in Italy?
Yes. AIFA authorised it on 9 November 2016.
Who is the marketing authorisation holder for Ibrance in Italy?
Pfizer Limited holds the Italian marketing authorisation.